Genome Editing for Neurodegenerative Diseases 1st Edition

Genome Editing for Neurodegenerative Diseases, 1st Edition by Sandeep Kumar Singh is an authoritative, contemporary guide that brings together molecular precision and clinical perspective to tackle disorders like Alzheimer’s, Parkinson’s, Huntington’s disease and ALS. Clear, well-structured and richly referenced, this volume appeals to neuroscientists, clinical researchers, translational teams and advanced students seeking practical knowledge on genome-editing strategies.

Begin with a concise introduction to editing platforms—CRISPR/Cas systems, base and prime editors—then move into disease-specific chapters that explain pathogenic mechanisms, target selection, delivery challenges and preclinical models. The text balances rigorous molecular detail with translational focus: safety profiling, off-target assessment, regulatory frameworks and ethical considerations essential for moving from bench to bedside. Case studies and comparative analyses illuminate current successes and limitations of in vivo and ex vivo approaches.

Readers will gain actionable insights into experimental design, vector choice, biomarker integration and pathways for clinical translation—helpful for researchers in academia, biotech, and clinical settings across North America, Europe, India and Asia-Pacific. The book’s clinical relevance, methodological clarity and forward-looking commentary make it ideal for designing studies, grant proposals and cross-disciplinary collaborations.

Concise yet comprehensive, Genome Editing for Neurodegenerative Diseases, 1st Edition by Sandeep Kumar Singh is an essential reference for anyone engaged in the global effort to develop precise, safe genetic interventions for neurodegenerative disorders. Order your copy today to stay at the forefront of genome-editing research and clinical innovation.

Note: eBooks do not include supplementary materials such as CDs, access codes, etc.